Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Melanoma of Unknown Primary

In: Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 7.
Affiliations
Free Books & Documents
Review

Melanoma of Unknown Primary

Jeffrey F. Scott et al.
Free Books & Documents

Excerpt

Although the vast majority of melanomas have a known primary site, approximately 3.2% of all melanomas present in distant sites with no known primary site. Melanoma of unknown primary most often presents in lymph nodes, followed by subcutaneous sites, and finally visceral organs. Various hypotheses regarding the origin of melanoma of unknown primary have been proposed, including spontaneous regression of the primary tumor, and the presence of ectopic melanocytes within lymph nodes and visceral organs. Melanoma of unknown primary is less well studied in comparison with melanoma of known primary, but its clinical, molecular, and genetic characteristics have been recently clarified. Specifically, melanoma of unknown primary occurs more often in men in the fourth and fifth decades of life, and shares a similar genetic and molecular signature as cutaneous melanomas arising on skin that is intermittently exposed to the sun, including the back and upper legs. In addition, the prognosis of these patients has also been clarified, and patients with melanoma of unknown primary have improved survival compared to stage-matched patients with melanoma of known primary. This chapter reviews recent advances in the understanding of melanoma of unknown primary, highlighting its genetic and molecular characteristics, epidemiology, prognosis, and treatment, as well as its relationship with melanoma of known primary site.

PubMed Disclaimer

References

    1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–78. doi: 10.1002/(SICI)1097-0142(19981015)83:8%3C1664::AID-CNCR23%3E3.0.CO;2-G. - DOI - PubMed
    1. Dasgupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary origin. Surg Gynecol Obstet. 1963;117:341–5. - PubMed
    1. Kamposioras K, Pentheroudakis G, Pectasides D, Pavlidis N. Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Crit Rev Oncol Hematol. 2011;78(2):112–26. doi: 10.1016/j.critrevonc.2010.04.007. - DOI - PubMed
    1. Bankar S, Patkar S, Desai S, Shrikhande SV. Unusual presentation of melanoma of unknown primary origin: A case report and review of literature. J Cancer Res Ther. 2015;11(4):1025. doi: 10.4103/0973-1482.148680. - DOI - PubMed
    1. Smith JL, Jr., Stehlin JS., Jr. Spontaneous regression of primary malignant melanomas with regional metastases. Cancer. 1965;18(11):1399–415. doi: 10.1002/1097-0142(196511)18:11%3C1399::AID-CNCR2820181104%3E3.0.CO;2-R. - DOI - PubMed

LinkOut - more resources